Among all of the 112 acral melanomas, BRAF V600E was positive in 21 melanomas (18.8%) and negative in the remaining 91 (81.3%), as determined using IHC with a mouse monoclonal VE1 antibody (ab228461; Abcam, Cambridge, UK). This evidence concerns the gene BRAF and melanoma.